1
The rats were scored for the development of clinical EAE and AU.
2
Anti-MIP-1alpha treatment had no effect on clinical EAE but inhibited the clinical signs of AU.
3
Conclusions: These results indicated that both strains attenuated clinical EAE manifestations, but only TSST-1 clearly decreased CNS inflammation.